Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov 13;23(17):2337-45.
doi: 10.1097/QAD.0b013e3283319184.

HIV infection and the risk of cancers with and without a known infectious cause

Michael J Silverberg  1 , Chun Chao, Wendy A Leyden, Lanfang Xu, Beth Tang, Michael A Horberg, Daniel Klein, Charles P Quesenberry Jr, William J Towner, Donald I Abrams
Affiliations

HIV infection and the risk of cancers with and without a known infectious cause

Michael J Silverberg et al. AIDS. .

Abstract

Objective: To evaluate the risk of cancers with and without a known infectious cause in HIV-infected persons.

Design: Retrospective cohort study.

Methods: Adult HIV-infected and matched HIV-uninfected members of Kaiser Permanente followed between 1996 and 2007 for incident AIDS-defining cancers (ADCs), infection-related non-AIDS-defining cancers (NADCs; anal squamous cell, vagina/vulva, Hodgkin's lymphoma, penis, liver, human papillomavirus-related oral cavity/pharynx, stomach) and infection-unrelated NADC (all other NADCs).

Results: We identified 20 277 HIV-infected and 202 313 HIV-uninfected persons. HIV-infected persons experienced 552 ADC, 221 infection-related NADC, and 388 infection-unrelated NADC. HIV-uninfected persons experienced 179 ADC, 284 infection-related NADC, and 3418 infection-unrelated NADC. The rate ratio comparing HIV-infected and HIV-uninfected persons for ADC was 37.7 [95% confidence interval (CI): 31.7-44.8], with decreases in the rate ratio over time (P < 0.001). The rate ratio for infection-related NADC was 9.2 (95% CI: 7.7-11.1), also with decreases in the rate ratio over time (P < 0.001). These results were largely influenced by anal squamous cell cancer and Hodgkin's lymphoma. The rate ratio for infection-unrelated NADC was 1.3 (95% CI: 1.2-1.4), with no change in the rate ratio over time (P = 0.44). Among infection-unrelated NADCs, other anal, skin, other head and neck, and lung cancer rates were higher and prostate cancer rates lower in HIV-infected persons. Among all infection-unrelated NADCs, the rate ratio decreased over time only for lung cancer (P = 0.007).

Conclusion: In comparison with those without HIV infection, HIV-infected persons are at particular risk for cancers with a known infectious cause, although the higher risk has decreased in the antiretroviral therapy era. Cancers without a known infectious cause are modestly increased in HIV-infected persons compared with HIV-uninfected persons.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Changes in age and CD4+ T-cell counts over time for study participants
Mean age of HIV-infected and HIV-unfected persons for years 1996 to 2007. Mean CD4+ T-cell counts over time also presented for HIV-infected persons. Numbers of HIV-infected and HIV-uninfected persons each year are also presented.
Figure 2
Figure 2. Calendar trends for cancers in HIV-infected and HIV-uninfected persons
Crude incidence rates for any infection-related NADC and any infection-unrelated NADC presented for years 1996–99, 2000–03, and 2004–07. Also presented are individual cancers that either showed statistically significant trends among HIV-infected persons, or differences in trends comparing HIV-infected and HIV-uninfected persons. Annual % change in cancer rates obtained from Poisson regression models adjusting for HIV status, age, sex, calendar period (continuous) and HIV status/calendar period interaction. P-values are presented for annual % change within groups, and for the comparison of HIV+ vs. HIV− annual % change.
See this image and copyright information in PMC

References

    1. Crum-Cianflone N, Hullsiek KH, Marconi V, Weintrob A, Ganesan A, Barthel RV, et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. Aids. 2009;23:41–50. - PMC - PubMed
    1. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008;123:187–194. - PubMed
    1. Silverberg MJ, Neuhaus J, Bower M, Gey D, Hatzakis A, Henry K, et al. Risk of cancers during interrupted antiretroviral therapy in the SMART study. Aids. 2007;21:1957–1963. - PubMed
    1. Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med. 2008;148:728–736. - PubMed
    1. Silverberg MJ, Abrams DI. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era. Curr Opin Oncol. 2007;19:446–451. - PubMed

Publication types

MeSH terms